Effect of HPV16 L1 virus-like particles on the aggregation of non-functionalized gold nanoparticles

被引:13
|
作者
Palomino-Vizcaino, Giovanni [1 ]
Valencia Resendiz, Diana Gabriela [1 ]
Luisa Benitez-Hess, Maria [1 ]
Martinez-Acuna, Natalia [1 ]
Virginia Tapia-Vieyra, Juana [1 ]
Bahena, Daniel [2 ]
Diaz-Sanchez, Mauricio [3 ]
Patricio Garcia-Gonzalez, Octavio [3 ]
Arizai Alvarez-Sandoval, Brenda [3 ]
Marat Alvarez-Salas, Luis [1 ]
机构
[1] Dept Genet & Biol Mol, Lab Terapia Genica, Mexico City, DF, Mexico
[2] Inst Politecn Nacl, LANE, Ctr Invest & EstudiosAvanzados, Mexico City, DF, Mexico
[3] Genes2Life SAPI CV, R D & Innovat Dept, Guanajuato, Mexico
来源
BIOSENSORS & BIOELECTRONICS | 2018年 / 100卷
关键词
Papillomavirus; Gold nanoparticles; Viral proteins; HPV; Virus-like particles; Molecular interaction; Binding; PROMISING PEROXIDASE MIMETICS; MAJOR CAPSID PROTEIN; HUMAN-PAPILLOMAVIRUS; HEPARAN-SULFATE; COLORIMETRIC DETECTION; BIOMEDICAL APPLICATIONS; H2O2; ADSORPTION; APTAMER; NANOCOMPOSITES;
D O I
10.1016/j.bios.2017.09.001
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Colorimetric assays based on gold nanoparticles (GNPs) are of considerable interest for diagnostics because of their simplicity and low-cost. Nevertheless, a deep understanding of the interaction between the GNPs and the intended molecular target is critical for the development of reliable detection technologies. The present report describes the spontaneous interaction between HPV16 L1 virus-like particles (VLPs) and non-functionalized GNPs (nfGNPs) resulting in the inhibition of nfGNPs salt-induced aggregation and the stabilization of purified VLPs. Ionic-competition experiments suggested that the nature of nfGNPs-VLPs interaction is non-covalent. Adsorption of an RNA aptamer on nfGNPs surface showed an additive aggregation-inhibitory effect. The use of mutant VLPs confirmed that the interaction nfGNPs-VLPs is not mediated by the opposing superficial electrostatic charges, suggesting that non-electrostatic forces participate in the arrangement of nfGNPs on the VLPs surface. Competition experiments using increasing ethanol concentrations on nfGNPs-VLPs complexes suggested hydrophobic interactions as the main stabilizing force. Therefore, the nfGNPs-VLPs interaction described here should facilitate the development of adsorption assays based on nfGNPs for HPV detection and cervical cancer prevention.
引用
收藏
页码:176 / 183
页数:8
相关论文
共 50 条
  • [41] Displaying 31RG-1 peptide on the surface of HPV16 L1 by use of a human papillomavirus chimeric virus-like particle induces cross-neutralizing antibody responses in mice
    Chen, Xue
    Zhang, Ting
    Liu, Hongyang
    Hao, Yaru
    Liao, Guoyang
    Xu, Xuemei
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (08) : 2025 - 2033
  • [42] Physicochemical characterization and immunological properties of Pichia pastoris based HPV16L1 and 18L1 virus like particles
    Gupta, Gaurav
    Glueck, Reinhard
    Rishi, Narayan
    BIOLOGICALS, 2017, 46 : 11 - 22
  • [43] Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses
    Hainisch, E. K.
    Brandt, S.
    Shafti-Keramat, S.
    Van Den Hoven, R.
    Kirnbauer, R.
    EQUINE VETERINARY JOURNAL, 2012, 44 (01) : 107 - 111
  • [44] VLP production in Leishmania tarentolae: A novel expression system for purification and assembly of HPV16 L1
    Bolhassani, Azam
    Shirbaghaee, Zeinab
    Agi, Elnaz
    Davoudi, Noushin
    PROTEIN EXPRESSION AND PURIFICATION, 2015, 116 : 7 - 11
  • [45] Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells
    Mossadegh, N
    Gissmann, L
    Müller, M
    Zentgraf, H
    Alonso, A
    Tomakidi, P
    VIROLOGY, 2004, 326 (01) : 57 - 66
  • [46] Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay
    Robbins, Hilary A.
    Waterboer, Tim
    Porras, Carolina
    Kemp, Troy J.
    Pawlita, Michael
    Cecilia Rodriguez, Ana
    Wacholder, Sholom
    Gonzalez, Paula
    Schiller, John T.
    Lowy, Douglas R.
    Esser, Mark
    Matys, Katie
    Poncelet, Sylviane
    Herrero, Rolando
    Hildesheim, Allan
    Pinto, Ligia A.
    Safaeian, Mahboobeh
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (10) : 2965 - 2974
  • [47] Development of a non-denaturing electrophoresis system for characterization of neutralizing epitopes on HPV virus-like particles
    Studentsov, Yevgeniy Y.
    Burk, Robert D.
    JOURNAL OF VIROLOGICAL METHODS, 2007, 139 (02) : 208 - 219
  • [48] Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas
    Tsakogiannis, Dimitris
    Nikolaidis, Marios
    Zagouri, Flora
    Zografos, Eleni
    Kottaridi, Christine
    Kyriakopoulou, Zaharoula
    Tzioga, Lamprini
    Markoulatos, Panayotis
    Amoutzias, Grigoris D.
    Bletsa, Garyfalia
    VIRUSES-BASEL, 2023, 15 (01):
  • [49] Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic
    Millan, Alicia Fernandez-San
    Ortigosa, Susana M.
    Hervas-Stubbs, Sandra
    Corral-Martinez, Patricia
    Segui-Simarro, Jose M.
    Gaetan, Julien
    Coursaget, Pierre
    Veramendi, Jon
    PLANT BIOTECHNOLOGY JOURNAL, 2008, 6 (05) : 427 - 441
  • [50] Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
    Olsson, Sven-Eric
    Villa, Luisa L.
    Costa, Ronaldo L. R.
    Petta, Carlos A.
    Andrade, Rosires P.
    Malm, Christian
    Iversen, Ole-Erik
    Hoye, John
    Steinwall, Margareta
    Riis-Johannessen, Grete
    Andersson-Ellstrom, Agneta
    Elfgren, Kristina
    von Krogh, Geo
    Lehtinen, Matti
    Paavonen, Jorma
    Tamms, Gretchen M.
    Giacoletti, Katherine
    Lupinacci, Lisa
    Esser, Mark T.
    Vuocolo, Scott C.
    Saah, Alfred J.
    Barr, Eliav
    VACCINE, 2007, 25 (26) : 4931 - 4939